{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:18:15Z","timestamp":1767849495026,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012068","name":"Health and Care Research Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jval.2023.03.2429","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:27:24Z","timestamp":1681298844000},"page":"1192-1200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non\u2013Small Cell Lung Cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Mari","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Lowin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel Elizabeth","family":"Gemine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Elizabeth","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Lanyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keir E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10292","key":"10.1016\/j.jval.2023.03.2429_bib2","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/S0140-6736(21)01169-7","article-title":"Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jval.2023.03.2429_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/tobaccocontrol-2016-053305","article-title":"Global economic cost of smoking-attributable diseases","volume":"27","author":"Goodchild","year":"2018","journal-title":"Tob Control"},{"key":"10.1016\/j.jval.2023.03.2429_bib7","series-title":"Supporting Tobacco Cessation","first-page":"165","article-title":"Lung cancer patients","author":"Gemine","year":"2021"},{"key":"10.1016\/j.jval.2023.03.2429_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2018.12.028","article-title":"Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small cell lung cancer","volume":"129","author":"Gemine","year":"2019","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.jval.2023.03.2429_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/JTO.0b013e318195e23a","article-title":"Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer","volume":"4","author":"Slatore","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"issue":"11","key":"10.1016\/j.jval.2023.03.2429_bib11","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s40273-019-00844-y","article-title":"TECH-VER: a verification checklist to reduce errors in models and improve their credibility","volume":"37","author":"B\u00fcy\u00fckkaramikli","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2023.03.2429_bib13","first-page":"CD013229","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis","volume":"1","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jval.2023.03.2429_bib14","series-title":"Decision Modelling for Health Economic Evaluation","author":"Sculpher","year":"2006"},{"issue":"11","key":"10.1016\/j.jval.2023.03.2429_bib15","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/add.15086","article-title":"Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study","volume":"115","author":"Li","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.jval.2023.03.2429_bib16","series-title":"Internal correspondence","year":"2019"},{"key":"10.1016\/j.jval.2023.03.2429_bib18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.lungcan.2018.06.007","article-title":"Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: a retrospective observational study (LuCaBIS)","volume":"124","author":"Andreas","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jval.2023.03.2429_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/CEOR.S223760","article-title":"Costs and cost drivers associated with non-small-cell lung cancer patients who received two or more lines of therapy in Europe","volume":"12","author":"Verleger","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"issue":"2","key":"10.1016\/j.jval.2023.03.2429_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s41669-020-00245-4","article-title":"Cost effectiveness of nivolumab in patients with advanced, previously treated squamous and non-squamous non-small-cell lung cancer in England","volume":"5","author":"Rothwell","year":"2021","journal-title":"Pharmacoecon Open"},{"issue":"1","key":"10.1016\/j.jval.2023.03.2429_bib21","article-title":"Health economic analysis for the \u2018CURE Project\u2019 pilot: a hospital-based tobacco dependency treatment service in Greater Manchester","volume":"8","author":"Evison","year":"2021","journal-title":"BMJ Open Respir Res"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301523025299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301523025299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:32:02Z","timestamp":1761096722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301523025299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1098301523025299"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2023.03.2429","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non\u2013Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2023.03.2429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}